PRICE T ROWE ASSOCIATES INC /MD/ - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$890
+75.2%
129,887
+165.2%
0.00%
Q2 2023$508
+31.9%
48,980
+3.2%
0.00%
Q1 2023$385
-47.7%
47,468
+1.6%
0.00%
Q4 2022$736
-99.9%
46,712
-0.8%
0.00%
Q3 2022$742,000
+39.7%
47,106
+23.9%
0.00%
Q2 2022$531,000
-2.4%
38,029
+20.5%
0.00%
Q1 2022$544,000
+15.7%
31,569
-2.4%
0.00%
Q4 2021$470,000
-20.2%
32,343
-1.2%
0.00%
Q3 2021$589,000
-20.1%
32,742
-22.0%
0.00%
Q2 2021$737,000
+0.4%
41,977
+44.2%
0.00%
Q1 2021$734,000
+2058.8%
29,120
-7.2%
0.00%
Q3 2019$34,000
-50.0%
31,393
+0.5%
0.00%
Q2 2019$68,000
+7.9%
31,246
+199.1%
0.00%
Q1 2019$63,000
-99.3%
10,446
-96.9%
0.00%
-100.0%
Q3 2017$8,784,000
-20.6%
340,343
-16.5%
0.00%0.0%
Q2 2017$11,058,000
+7.7%
407,743
+18.4%
0.00%0.0%
Q1 2017$10,268,000344,3170.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 441,000$833,0002.78%
MFN Partners Management, LP 4,000,000$7,560,0001.56%
Endurant Capital Management LP 2,055,069$3,884,0001.22%
Broadfin Capital, LLC 1,888,039$3,568,0000.48%
Aisling Capital Management LP 634,455$1,199,0000.46%
EcoR1 Capital, LLC 2,087,312$3,945,0000.36%
Sofinnova Investments, Inc. 1,911,573$3,613,0000.26%
Alambic Investment Management, L.P. 115,036$217,0000.18%
Parkman Healthcare Partners LLC 225,000$425,0000.12%
Rock Springs Capital Management LP 1,600,000$3,024,0000.10%
View complete list of ACLARIS THERAPEUTICS INC shareholders